Company Profile
Hoth Therapeutics Stock Price, News & Analysis
- Ticker:
- HOTH
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.36 USD (+92.01%)
Close
Last updated: May 27, 2026
26M USD
Market cap
Why the stock is moving
Current closing-price context is not available for HOTH.
Company overview
Business overview
Hoth Therapeutics is a biotechnology company focused on developing therapies across dermatology, inflammation, and oncology. Its story is built around a broad but still early-stage development portfolio.
Geographic Base and Sector Classification
Hoth is headquartered in the United States and listed on NASDAQ. It sits in small-cap specialty biopharma.
Business Model Characteristics
The company depends on preclinical and early clinical progress, capital efficiency, and the ability to prioritize programs. Investors usually watch proof-of-concept data and strategic changes.
Position Within the Biotechnology Landscape
Hoth occupies a speculative small-cap biotech niche. Its stock tends to move on program updates because the company is still shaping its identity.
Future catalysts
Hoth’s catalysts are its dermatology and inflammatory-disease programs, plus any strategic update that clarifies which assets still matter. The market will care about whether the company can keep a viable development path.
Recent news
- 01
- 02
Hoth Therapeutics Inc. Announces Closing of Initial Public Offering
Source: Hoth Therapeutics
- 03
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Hoth Therapeutics (HOTH)?
Hoth Therapeutics (HOTH) most recently closed at 1.36 USD, a +92.01% move versus the previous session.
What is the market cap of Hoth Therapeutics (HOTH)?
Hoth Therapeutics currently has a market capitalization of 26M USD on BioPharmSignal.
What does Hoth Therapeutics do?
Hoth Therapeutics is a biotechnology company focused on developing therapies across dermatology, inflammation, and oncology. Its story is built around a broad but still early-stage development portfolio.
On which exchange is HOTH stock listed?
Hoth Therapeutics (HOTH) is associated with NASDAQ, United States, Biopharma.
What is Hoth?
Hoth’s catalysts are its dermatology and inflammatory-disease programs, plus any strategic update that clarifies which assets still matter.
Which conditions is Hoth Therapeutics targeting with Hoth?
Hoth Therapeutics is associated with oncology, inflammatory disease, dermatology based on its company overview and current catalyst commentary.
How does Hoth Therapeutics describe recent progress with Hoth?
Hoth’s catalysts are its dermatology and inflammatory-disease programs, plus any strategic update that clarifies which assets still matter.
What is Therapeutics?
Hoth Therapeutics is a biotechnology company focused on developing therapies across dermatology, inflammation, and oncology.